These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 15623598

  • 1. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
    Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI.
    Clin Cancer Res; 2004 Dec 15; 10(24):8229-34. PubMed ID: 15623598
    [Abstract] [Full Text] [Related]

  • 2. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T, Kondo S.
    J Surg Res; 2008 May 01; 146(1):32-42. PubMed ID: 17543340
    [Abstract] [Full Text] [Related]

  • 3. Profiling markers of prognosis in colorectal cancer.
    Lyall MS, Dundas SR, Curran S, Murray GI.
    Clin Cancer Res; 2006 Feb 15; 12(4):1184-91. PubMed ID: 16489072
    [Abstract] [Full Text] [Related]

  • 4. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G.
    Anticancer Res; 2000 Feb 15; 20(2B):1085-91. PubMed ID: 10810401
    [Abstract] [Full Text] [Related]

  • 5. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.
    Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P, Besig S, Rad R, Braun T, Baur DM, Perren A, Langer R, Höfler H, Prinz C.
    Neuroendocrinology; 2009 Jul 15; 89(1):66-78. PubMed ID: 18708724
    [Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA, Bergin FG, Leaper DJ.
    Br J Surg; 2000 Sep 15; 87(9):1215-21. PubMed ID: 10971431
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M, Topolcan O, Holubec L, Rupert K, Cerna M, Holubec LS, Treska V, Finek J, Cerny R.
    Anticancer Res; 2007 Sep 15; 27(4A):1863-7. PubMed ID: 17649785
    [Abstract] [Full Text] [Related]

  • 10. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
    Wan Y, Wei Q, Pan Y, Liu Y.
    Zhonghua Wai Ke Za Zhi; 2000 Jul 15; 38(7):510-3. PubMed ID: 11832095
    [Abstract] [Full Text] [Related]

  • 11. Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.
    Massi D, Franchi A, Ketabchi S, Paglierani M, Pimpinelli N, Santucci M.
    Hum Pathol; 2003 Jan 15; 34(1):80-8. PubMed ID: 12605370
    [Abstract] [Full Text] [Related]

  • 12. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 13. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.
    Am J Clin Oncol; 2008 Feb 15; 31(1):55-63. PubMed ID: 18376229
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S, Pääkkö P, Soini Y, Mäkitaro R, Kinnula V, Turpeenniemi-Hujanen T.
    Cancer Lett; 2006 May 08; 236(1):125-32. PubMed ID: 15982804
    [Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T, Kuester D, Boltze C, Schulz TO, Samii A, Herold C, Ostertag H, Roessner A.
    Hum Pathol; 2008 Feb 08; 39(2):217-23. PubMed ID: 17949787
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
    McKenna GJ, Meneghetti A, Chen YL, Mui AL, Ong C, Scudamore CH, McMaster WR, Owen DA, Chung SW.
    J Surg Oncol; 2005 Jun 15; 90(4):239-46. PubMed ID: 15906368
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
    Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS.
    Clin Cancer Res; 2001 Oct 15; 7(10):3113-9. PubMed ID: 11595703
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.
    Int J Mol Med; 2005 Oct 15; 16(4):541-6. PubMed ID: 16142384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.